Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee

Autor: Gary W. Moore, Elisabetta Castoldi, Jun Teruya, Eriko Morishita, Dorothy M. Adcock

Publikováno v: Journal of Thrombosis and Haemostasis, 21(1), 164-174. Wiley

Activated protein C resistance (APC-R) due to the single-nucleotide polymorphism factor V Leiden (FVL) is the most common cause of hereditary thrombophilia. It is found predominantly in Caucasians and is uncommon or absent in other populations. Altho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe677068dd76fbc4231edfa8937491f
https://cris.maastrichtuniversity.nl/en/publications/7dc435cf-19ff-4a7e-8bba-8f713ddc3570

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Autor: Robert C. Gosselin, Edelgard Lindhoff-Last, Steve Kitchen, Yohko Kawai, Cecilia Guillermo, Jonathan Douxfils, Isabelle Gouin-Thibault, Shannon M. Bates, Emmanuel J. Favaloro, Dorothy M. Adcock

Publikováno v: Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2021, 121 (08), pp.1008-1020. ⟨10.1055/a-1450-8178⟩
Thrombosis and Haemostasis, 2021, 121 (08), pp.1008-1020. ⟨10.1055/a-1450-8178⟩
Douxfils, J, Adcock, D, Bates, S M, Favaloro, E J, Gouin-Thibault, I, Guillermo, C, Kawai, Y, Lindhoff-Last, P D E, Kitchen, S & Gosselin, R C 2021, ' 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants ', Thrombosis and Haemostasis, vol. 121, no. 8, pp. 1008-1020 . https://doi.org/10.1055/a-1450-8178

In 2018, the International Council for Standardization in Haematology (ICSH) published a consensus document providing guidance for laboratories on measuring direct oral anticoagulants (DOACs). Since that publication, several significant changes relat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ad27953a22ebe90e95e77abd1a626bb
https://hal.archives-ouvertes.fr/hal-03280814

Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial

Autor: Vimal K. Derebail, Jing Zhu, Matthew L. Crawford, Julia R. Garnier, Karlyn A. Martin, Sarah Skinner, Tejendra Patel, Anne Froment, Margaret R. Sketch, Andy H. Szeto, Sheel M. Patel, Chad D. Torrice, Stefan Tiefenbacher, Dorothy M. Adcock, Russell P. Grant, Nigel S. Key, Daniel J. Crona

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c33e5bda08b7e7504aa6241ff02bde89
https://pubmed.ncbi.nlm.nih.gov/36328100

Screening Coagulation Assays, Factor XIII and D-dimer

Autor: Dorothy M. Adcock, Brian F. Poirier

Publikováno v: Management of Bleeding Patients ISBN: 9783030563370

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e52df9387d70ba1e50e1c617f49698a
https://doi.org/10.1007/978-3-030-56338-7_2

Educational needs of hematologists and laboratory professionals regarding factor activity assays

Autor: Mazi Rasulnia, Natalia Holot, Dorothy M Adcock, David L. Cooper

Publikováno v: Journal of Blood Medicine

Dorothy M Adcock,1 Mazi Rasulnia,2 Natalia Holot,3 David L Cooper3 1Laboratory Corporation of America Holdings, Burlington, NC, 2M Consulting LLC, Birmingham, AL, 3Clinical, Medical, and Regulatory Affairs,Novo Nordisk Inc., Plainsboro, NJ, USA Intro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93fee1b6fd4c91d203be27ec0d82403a
http://europepmc.org/articles/PMC5908211